Suppr超能文献

无细胞百日咳疫苗成分:现状与未来。

Acellular Pertussis Vaccine Components: Today and Tomorrow.

作者信息

Dewan Kalyan K, Linz Bodo, DeRocco Susan E, Harvill Eric T

机构信息

Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.

The Lockwood Group, Stamford, CT 06901, USA.

出版信息

Vaccines (Basel). 2020 May 13;8(2):217. doi: 10.3390/vaccines8020217.

Abstract

Pertussis is a highly communicable acute respiratory infection caused by Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed to control disease. Whole-cell pertussis (wP) vaccines became available in the 1940s but have been replaced in many countries with acellular pertussis (aP) vaccines. This review summarizes disease epidemiology before and after the introduction of wP and aP vaccines, discusses the rationale and clinical implications for antigen inclusion in aP vaccines, and provides an overview of novel vaccine strategies aimed at better combating pertussis in the future.

摘要

百日咳是一种由[未提及的病原体]引起的高度传染性急性呼吸道感染。自然感染或接种疫苗后免疫力并非终身存在。百日咳疫情在全球呈周期性爆发,需要有效的疫苗接种策略来控制疾病。全细胞百日咳(wP)疫苗于20世纪40年代问世,但在许多国家已被无细胞百日咳(aP)疫苗所取代。本综述总结了wP和aP疫苗引入前后的疾病流行病学,讨论了aP疫苗中抗原包含的基本原理和临床意义,并概述了旨在未来更好地对抗百日咳的新型疫苗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6567/7349526/860a5d11e53d/vaccines-08-00217-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验